• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Belite Bio, Inc

Belite Bio, Inc

Public
BLTE
United States
SectorHealthcare
CountryUnited States
Market cap6.59B
A clinical-stage biopharmaceutical company focused on developing novel oral treatments for degenerative retinal eye diseases.

Where to buy Belite Bio, Inc (BLTE)

BLTE trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare